newsfilter
← Latest News
ACCESS Newswire·

Aspire Biopharma Announces the Appointment of New Member to Its Board of Directors

New independent director Phillip Balatsos brings commercial and capital markets expertise to drive development patent-pending drug delivery platformESTERO, FL / ACCESS Newswire / February 13, 2026 / Aspire Biopharma